SCHEMBL4599166

SCHEMBL4599166

Cc1ccc(S(=O)(=O)Oc2cc[c]c(NC(C)(C)C)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CA2 P00918 3/20 0.38
CA12 O43570 2/20 0.38
ENPP2 Q13822 4/20 0.37
GPR17 Q13304 1/20 0.37
ENPP3 O14638 3/20 0.37
ENPP1 P22413 3/20 0.37
MAOB P27338 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.36
G6PD P11413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600277 0.85 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL6664715 0.82 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL3454513 0.82 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4599803 0.80 ALDH1A1 (0.42) ALDH1A1HPGDCA2CA12GAA
SCHEMBL4599126 0.78 MEN1 (0.41) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4599999 0.77 L3MBTL1 (0.45) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4598894 0.76 MEN1 (0.49) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4599252 0.75 ALDH1A1 (0.51) MEN1KMT2AALDH1A1LMNAHTT
SCHEMBL4599861 0.75 GAA (0.40) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4600500 0.72 ALDH1A1 (0.48) ALDH1A1LMNAHTTL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed